Related Experiment Video
Updated: Dec 13, 2025

12:36
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
9.8K
Mapping systemic lupus erythematosus heterogeneity at the single-cell level
Djamel Nehar-Belaid1, Seunghee Hong2, Radu Marches1
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Nature Immunology
|August 5, 2020
Summary
Single-cell sequencing reveals specific cell subpopulations drive systemic lupus erythematosus (SLE) gene expression. These interferon-stimulated gene-high (ISG-high) cells and unique subpopulations correlate with disease activity in children and adults with SLE.
Area of Science:
- Immunology
- Genomics
- Computational Biology
Background:
- Systemic lupus erythematosus (SLE) exhibits a complex blood transcriptome.
- The cellular origins of SLE's transcriptional signatures remain unclear.
Purpose of the Study:
- To identify the specific cell types and subpopulations responsible for the SLE transcriptome.
- To investigate the link between these cellular signatures and SLE disease activity.
Main Methods:
- Single-cell RNA sequencing of ~276,000 peripheral blood mononuclear cells (PBMCs) from 33 children with SLE and 11 controls.
- Analysis of ~82,000 PBMCs from adults with SLE.
- Identification of interferon-stimulated gene-high (ISG-high) signatures and associated subpopulations.
Main Results:
- Increased ISG expression was observed in cells from children with SLE compared to controls.
- ISG-high signatures originated from specific subpopulations within monocytes, T cells, NK cells, dendritic cells, B cells, and plasma cells.
- Expansion of ISG-high and/or monogenic lupus-associated gene-enriched subpopulations correlated with higher SLE disease activity in both children and adults.
Conclusions:
- This study resolves the cellular origin of SLE transcriptional signatures.
- Identified subpopulations provide insights into SLE heterogeneity and disease severity.
- Findings pave the way for precision medicine approaches in SLE treatment.

